Multiple Sclerosis International
Overview
Multiple Sclerosis International is a scientific journal, published by Wiley since 2010 in English. The journal's country of origin is United States.
Details
Details
Abbr.
Mult Scler Int
Publisher
Wiley
Start
2010
End
2024
p-ISSN
2090-2654
e-ISSN
2090-2662
Country
United States
Language
English
Recent Articles
21.
Taan M, Al Ahmad F, Ercksousi M, Hamza G
Mult Scler Int
. 2021 Jun;
2021:8147451.
PMID: 34123428
Objectives: To assess the probable risk factors associated with Multiple sclerosis among Syrian patients in the city of Damascus. Method: In a case-control study conducted from May to September 2020,...
22.
Gulde P, Hermsdorfer J, Rieckmann P
Mult Scler Int
. 2021 Jun;
2021:5589562.
PMID: 34123427
Introduction: Improved gait is one of the leading therapy goals in multiple sclerosis. A plethora of clinical timed trials and state-of-the-art technology-based approaches are available to assess gait performance. Objectives:...
23.
Bonnan M, Ferrari S, Courtade H, Money P, Desblache P, Barroso B, et al.
Mult Scler Int
. 2021 Mar;
2021:8813498.
PMID: 33763241
Background: The progressive phase of multiple sclerosis (MS) is characterized by an intrathecal (IT) compartmentalization of inflammation, involving B-cells within meningeal follicles, and resisting all the available immunosuppressive treatments. A...
24.
Al Jumah M, Kojan S, Alroughani R, Cupler E, Bohlega S, Daif A, et al.
Mult Scler Int
. 2021 Mar;
2021:6681431.
PMID: 33747564
Few studies examine health-related quality of life (HRQoL) in Arabic-speaking multiple sclerosis (MS) patients. However, HRQoL tools such as the Short Form-36 QoL instrument (SF-36) and the Multiple Sclerosis International...
25.
Al Jumah M, Al Malik Y, Alkhawajah N, Saeedi J, AlThubaiti I, Bohlega S, et al.
Mult Scler Int
. 2021 Feb;
2021:6667006.
PMID: 33628508
More than half of all patients with multiple sclerosis (MS) in the Kingdom of Saudi Arabia (KSA) are women of childbearing age. Raising a family is an important life goal...
26.
Mustafa W, Elgendy N, Salama S, Jawad M, Eltoukhy K
Mult Scler Int
. 2021 Feb;
2021:6611897.
PMID: 33628507
Background: Multiple studies have reported that cannabis administration in multiple sclerosis patients is associated with decreased symptom severity. This study was conducted to evaluate the prevalence of cannabis abuse in...
27.
Basak J, Majsterek I
Mult Scler Int
. 2021 Jan;
2021:8825588.
PMID: 33505725
Multiple sclerosis (MS) is characterized by multifocal lesions, chronic inflammatory condition, and degenerative processes within the central nervous system (CNS) leading to demyelination. The most important cells involved in its...
28.
Moreira Ferreira V, Caefer D, Erlich-Malona N, Healy B, Chitnis T, Stankiewicz J
Mult Scler Int
. 2020 Dec;
2020:5471987.
PMID: 33381316
Objectives: To explore the safety and efficacy profile of teriflunomide in progressive multiple sclerosis. Methods: We conducted a single-center retrospective observational analysis of a progressive multiple sclerosis population, assessing safety...
29.
Edwards E, Kegelmeyer D, Kloos A, Nitta M, Raza D, Nichols-Larsen D, et al.
Mult Scler Int
. 2020 Sep;
2020:6707414.
PMID: 32963832
Background: Individuals with multiple sclerosis (MS) experience deficits in motor and cognitive domains, resulting in impairment in dual-task walking ability. The goal of this study was to compare performance of...
30.
Philippova E, Bazhenov I, Ziryanov A, Moskvina E
Mult Scler Int
. 2020 Aug;
2020:4652439.
PMID: 32774921
The Short Form Qualiveen (SF-Qualiveen) is an 8-item version of the Qualiveen questionnaire used to evaluate the impact of urinary symptoms on the quality of life in patients with urological...